Nanfei Yang
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Hierarchical Zeolitic Imidazolate Framework-8@Au Cluster Nanocarriers for In Situ Chimeric Antigen Receptor Macrophage Programming and Immunotherapy in Prostate Cancer.
Journal: ACS nano
Published: April 08, 2026
Discovery of a novel binding pocket in PPARγ for partial agonists: structure-based virtual screening identifies ginsenoside Rg5 as a partial agonist promoting beige adipogenesis.
Journal: Frontiers in chemistry
Published: February 19, 2025
FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 28, 2024
An electrochemical immunosensor for sensitive and rapid detection of cystatin C based on Fe3O4/AuNPs-MWCNTs@PDA nanocomposite.
Journal: Analytical biochemistry
Published: May 23, 2024
Lipid synthesis, triggered by PPARγ T166 dephosphorylation, sustains reparative function of macrophages during tissue repair.
Journal: Nature communications
Published: January 03, 2024
A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy.
Journal: Acta pharmaceutica Sinica. B
Published: October 16, 2022
Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions.
Journal: Cell death and differentiation
Published: April 03, 2022
Crosstalk between IL-15Rα+ tumor-associated macrophages and breast cancer cells reduces CD8+ T cell recruitment.
Journal: Cancer communications (London, England)
Published: October 18, 2021
Triple signal amplification strategy for the ultrasensitive electrochemical detection of human papillomavirus 16 E6/E7 mRNA.
Journal: Enzyme and microbial technology
Published: March 26, 2021
Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.
Journal: Cell death & disease
Published: September 23, 2020
CDK5 Inhibition Abrogates TNBC Stem-Cell Property and Enhances Anti-PD-1 Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 17, 2020
Last Updated: 09/26/2026